6th IAS Conference On HIV Pathogenesis, Treatment and Prevention


48-week results of a dual-therapy regimen of once-daily maraviroc (MVC) 150 mg in combination with ritonavir-boosted atazanavir (ATV/r) compared to emtricitabine/tenofovir (FTC/TDF) + ATV/r in treatment-naïve (TN) patients infected with CCR5-tropic HIV-1 TUAB0103


Time: 11:30
Speaker: Anthony Mills




You can download the mp3 file here



For more information on this presentation, including access to speaker presentations, please see the conference Programme-at-a-Glance page.


Contact Us | Site map © 2011 International AIDS Society